Abstract. Neuromedin-U (NMU) is a brain-gut peptide, which has been previously found to stimulate hypothalamicpituitary-adrenal axis in the rat. Enucleation-induced adrenal regeneration in rats with contralateral adrenalectomy is a well-established model of adrenal growth, that not only depends on the compensatory ACTH hypersecretion, but is also modulated by several regulatory peptides. Hence, we investigated whether NMU may be included in this group of bioactive molecules. Reverse transcription-polymerase chain reaction and immunocytochemistry showed that regenerating rat adrenocortical cells at days 5 and 8 after surgery express the NMU receptor NMUR1 as mRNA and protein. NMU8 administration to rats bearing regenerating adrenals markedly raised the plasma concentration of corticosterone and notably enhanced proliferative activity of adrenocortical cells. ACTH blood level was unchanged at day 5 and significantly decreased at day 8. The conclusion is drawn that NMU stimulates regeneration of rat adrenal cortex, via a mechanism independent of pituitary ACTH and involving the activation of NMUR1 located on adrenocortical cells.
Introduction
Neuromedin U (NMU) is a brain-gut peptide involved in the regulation of energy homeostasis and neuroendocrine functions. NMU acts via two subtypes of G protein-coupled receptors, NMUR1 and NMUR2, the former being the peripheral receptor and the latter the central one (reviewed in refs. 1,2). As in the case of other peptides modulating energy homeostasis and food intake (e.g. NPY, cholecystokinin, galanin, leptin, orexins, NPW and beacon) (3) (4) (5) (6) (7) (8) (9) , also NMU appears to regulate the hypothalamic-pituitary-adrenal (HPA) axis (10) (11) (12) (13) (14) (15) (16) . Since the expression of NMU gene was not detected in the rat adrenal, but adrenocortical cells are provided with NMUR1 (17, 18) , it is likely that NMU acts on this gland via a classic endocrine route.
Enucleation-induced adrenal regeneration is a classic model of rapid adrenocortical growth (19, 20) , that is modulated apart from ACTH, by several other regulatory peptides: adrenomedullin, galanin, orexins and arginin-vasopressin have been reported to stimulate, and leptin, enkephalin and perhaps beacon to inhibit adrenal regeneration (8, 23, 24) . Evidence has been recently provided that NMU8, that contains the 7-amino acid C-terminal active sequence of the native 23-amino acid peptide (25) , enhances proliferation of immature rat adrenocortical cells in primary culture (18) . Hence, it seemed worthwhile to investigate the expression of NMUR1 in and the effects of NMU8 administration on the regenerating rat adrenal cortex.
Materials and methods

Animals and reagents.
Female Wistar rats (final body weight 100-110 g) were kept under a 14:10 h light-dark cycle (illumination onset at 6:00 a.m.) at 23˚C, and maintained under a standard diet and tap water ad libitum. The study protocol was approved by the local Ethics Committee for Animal Studies. NMU8 was purchased from Bachem (Bubbendorf, Switzerland), and vincristine from Gedeon-Richter (Budapest, Hungary). Rabbit anti-rat NMUR1 polyclonal primary antibody was provided by Alpha Diagnostic International (San Antonio, TX), and secondary peroxidase-conjugated anti-rabbit IgG polyclonal antibodies by Amersham Biosciences (Piscataway, NJ). All other chemicals and reagents were obtained from Sigma-Aldrich Corp. (St. Louis, MO).
Experimental design. Under ether anesthesia and via dorsal approach, the left adrenal gland was enucleated and the contralateral gland removed (22) . A group of animals was sham-operated (intact adrenals). Rats were sacrificed 5 or 8 days after surgery, and their intact or regenerating adrenals were removed. Specimens were partly frozen at -80˚C for reverse transcription (RT)-polymerase chain reaction (PCR) assay (n=6), and partly fixed in Bouin's solution and embedded in paraffin for immunocytochemistry (ICC). Other rats bearing regenerating adrenals were divided into two experimental groups (n=8). One group was given three subcutaneous injections of 1.5 nmoles/100 g body weight of NMU8 dissolved in 0.2 ml 0.9% saline 24, 16 and 8 h before sacrifice. The other group (control rats) received subcutaneous injection of vehicle. Three hours before sacrifice all rats were given an intraperitoneal injection of 0.1 mg/100 g body weight of vincristine. Animals were decapitated at 11:00 a.m., and their trunk blood was collected in the presence of 1 mg/ml EDTA. Plasma was separated and stored at -36˚C for hormone assay. Regenerating adrenals were removed and processed for light microscopy for metaphase-index assay and morphometric estimations.
RT-PCR.
Total RNA was extracted from the frozen specimens, and reverse transcribed to cDNA (26) (27) (28) (29) . PCR was carried out, as previously detailed (30) (31) (32) (33) , in a Roche LightCycler 2.0, using the following primers: NMUR1 sense (481-500), 5'-GCCATCTGGGTCTTCGCTAT-3' and antisense (797-816), 5'-CACCTGTCTGCGTTCCCTAT-3' (336 bp; accession number, AF242873). The PCR program was: denaturation step at 94˚C for 10 min, followed by 35 cycles of three amplification steps (94˚C for 30 sec, annealing at 55˚C for 60 sec and extension at 68˚C for 120 sec). To rule out the possibility of amplifying genomic DNA, one PCR was performed without prior RT of the RNA. Detection of the PCR amplification products was carried out by size fractionation on 2% agarose gel electrophoresis.
ICC. Paraffin-embedded regenerating adrenals were cut, and the sections (6 μm) were incubated with the primary anti-NMUR1 antibody (1:100 dilution) for 60 min at 4˚C. After washing, section were then incubated overnight at 37˚C with the secondary peroxidase-conjugated antibody, and peroxidase activity was detected using the DAB technique (Dako Liquid DAB substrate-chromogen system; Dako, Glostrup, Denmark). When necessary, nuclei were counterstained with hematoxylin. Negative controls were carried out by similarly treating adjacent sections and omitting the primary antibody (34) .
Metaphase index and morphometry. Sections (6 μm) were stained with hematoxylin and eosin, and metaphase index (number of vincristine-arrested metaphase cells per 1,000 cells) was calculated at a magnification of x400, by counting 5,000 cells in the outer cortex of each regenerating adrenal parenchyma (24) . The number of nuclei of adrenocortical cells was counted at a magnification of x400 in 50 fields (area, 0.003 mm 2 ) of the outer cortex of each regenerating adrenal, and the number of nuclei per mm 2 was calculated.
Hormone assay. ACTH aldosterone and corticosterone were extracted from plasma, and measured by RIA, as detailed earlier (51,52). Aldosterone RIA: sensitivity, 5 pg/ml; intraand interassay CVs, 5 and 7%, respectively. Corticosterone RIA: sensitivity, 50 pg/mL; intra-and interassay CVs, 7 and 9%, respectively.
Statistics. Data were expressed as means ± SEM, and the statistical significance of the differences among experimental groups was estimated using ANOVA, followed by the Duncan's multiple range test.
Results
RT-PCR detected the expression of NMU1 mRNA in intact adrenal cortex of sham-operated rats and regenerating adrenals at days 5 and 8 after surgery (Fig. 1) . ICC showed the presence of NMUR1-like immunoreactivity in the narrow band of regenerating cortex, as well as in small islets of adrenocortical cells located outside the connective capsule (Fig. 2) . NMU8 administration decreased ACTH plasma level at day 8 of regeneration, did not affect aldosterone blood concentration, and markedly raised the level of circulating corticosterone at days 5 and 8 after surgery (Fig. 3) . NMU8 treatment enhanced proliferative activity of regenerating adrenals at day 5 after surgery, and increased the number of adrenocortical cells per unit area at day 8 (Fig. 4) .
Discussion
The growth of the adrenal cortex during the early stages of regeneration can be divided into two phases: a differentiation period from days 0 to 3, and a high proliferation period from days 4 to 7; starting from day 8 the proliferative activity starts to decrease (37) . This type of adrenocortical growth resembles that occurring during early stages of organogenesis, and primarily depends on the hypersecretion of ACTH and other POMC-derived peptides ensuing from the decreased production of glucocorticoid hormones by the reduced mass of regenerating parenchyma. Optimal regeneration requires contralateral adrenalectomy because glucocorticoid secretion from the remaining intact adrenal prevents the increased ACTH secretion. As compared to sham-operated rats, animals bearing regenerating adrenals possess blood levels of ACTH 10-fold higher and of corticosterone markedly lower due to the reduced mass of secreting tissue. However, the synthetic glucocorticoid dexamethasone was found to inhibit adrenocortical cytogenesis in intact gland, but not in enucleationinduced regenerating adrenals (44-48), suggesting that, in addition to ACTH, other factors control adrenal regeneration. Some of these extra-pituitary ACTH factors may derive from the nervous system (19, 38, 41, 43) , while others may be represented by several regulatory peptides acting via a classic endocrine route or in a paracrine-autocrine manner (see Introduction).
Our present findings indicate that NMU may be included in the group of regulatory peptides acting as circulating hormones, and this contention is based on the following pieces of evidence: i) NMU is not expressed in adrenal cortex (17, 18) , but regenerating adrenocortical cells are provided with NMUR1, ii) the repeated subcutaneous administration of NMU enhances neocytogenesis in the regenerating adrenals during the period of their high proliferative activity (day 5), and markedly stimulates glucocorticoid secretion at both day 5 and 8 after surgery; and iii) NMU treatment does not affect the blood concentration of ACTH at day 5, and at day 8 decreases it, thereby ruling out the possibility that the secretion and growth promoting effects of the peptide may depend on the stimulation of the central branch of the HPA axis.
This last observation is in contrast to the earlier findings obtained in adult rats with intact adrenals, where NMU either centrally or peripherally administered has been reported to enhance ACTH and corticosterone secretion (10) (11) (12) (13) (14) (15) (16) . It is conceivable that the notable compensatory ACTH hypersecretion occurring during adrenal regeneration in contralaterally adrenalectomized rats may prevent or mask the slight NMU stimulating affect on hypothalamic-pituitary CRH-ACTH release. Moreover, the NMU-induced sizeable decrease in ACTH blood level at day 8 of regeneration could be connected to the marked 2.5-fold rise in corticosterone plasma level quenching the negative feed-back mechanism driving ACTH hypersecretion.
Earlier studies carried out in adult rats provided evidence that NMU effects adrenocortical cells, at least partly, mediated by a paracrine mechanism involving CRH-ACTH intramedullary system (10, 11) , as occurs for other adrenocortical secretagogue peptides such as interleukin-1ß and PACAP (reviewed in ref. 49 ). NMUR1 mRNA was detected in rat adrenal medulla (18) , and NMU was found to increase in the rat the blood concentration of catecholamines (50) , which are known to regulate adrenal cortex growth and secretion (18) . However, in enucleation-induced adrenal growth, regeneration of medullary cells occurs only at the later stages of organ healing, and therefore this indirect paracrine route of NMU action at days 5 and 8 after adrenal enucleation seems very unlikely if not impossible (20, 51) .
Collectively, our present findings allow us to conclude that NMU stimulates regeneration of rat adrenal cortex, through a mechanism independent of pituitary ACTH and involving NMUR1 located on adrenocortical cells.
